23. Symposium of the AGNP

Abstracts (HTML) List of Authors

Tadic, A.

From mouse models to human behavior: Testing candidate genes for alcoholism

Talib, L. L.

Decreased platelet phospholipase A2 activity in Alzheimer's disease and mild cognitive Impairment

Taracha, E.

Alanine aminopeptidase (AAP) activity in urine: A new marker of chronic alcohol abuse?
Combination of nephro- and hepatotoxicity of alcohol to improve diagnostic performance of markers of alcohol abuse

Tatsch, K.

Auditory Evoked Potentials and 123I-β-CIT-SPECT as predictors of the differential response to serotonergic versus noradrenergic antidepressants
Neurobiological effects of TMS: Functional neuroimaging of dopaminergic neurotransmission using SPECT and [123I] IBZM
D2 dopamine receptor occupancy during treatment with flupentixol decanoate in comparison to risperidone, olanzapine, clozapine, haloperidol and haloperidol decanoate – A 123I-IBZM SPECT study: D2 receptor occupancy under flupentixol decanoate

Tavares Jr, H.

Relationship between 31P-NMR spectroscopy and neuropsychological performance in schizophrenia

Teipel, S.

Polymorphisms in the microtubuli associated protein tau and Alzheimer’s disease

Teipel, S. J.

Rates of amygdala and hippocampus atrophy in Alzheimer’s disease (AD) – Correlations with cognitive decline
Age-related cortical gray matter reductions in non-demented adults with Down’s syndrome determined by magnetic resonance imaging with optimized voxel-based morphometry
A new polymorphism in the cell division cycle 2 gene is associated with Alzheimer’s disease and frontotemporal dementia
Decrease of amyloid β1–42 antibodies in serum of patients with Alzheimer's disease
Neural representation of cognitive changes within the visual system in the AD brain

Theisen, F. M.

Genetic aspects of antipsychotic induced body weight change

Theuring, F.

Reduced anxiety-related behaviour in transgenic mice overexpressing serotonin 1A receptors

Thron, A.

Memory deficits and altered hippocampal function in ecstasy (MDMA) users: evidence from neuropsychological, functional imaging (fMRI) and MR-spectroscopy studies
Neural correlates of working memory in pure and polyvalent ecstasy (MDMA) users

Thum, A.

Short and long term effects of mirtazapine and venlafaxine on sleep-EEG in patients with major depression
Polysomnographic evaluation of patients with different types of dementia and treatment with cholinsterase Inhibitors, first results
Actigraphy in patients with depression and schizophrenia concerning activity levels, sleep estimation and circadian rhythm

Thürauf, N.

CYP2D6-Genotyping in clinical practice: Impact of Genotyp on serum concentrations of psychiatric relevant CYP2D6-substrates
Contribution of the CYP2D6 genotype to the occurrence of side-effects and of therapeutic failure during treatment with CYP2D6-dependent antidepressants

Toll, C.

A new measure of the dopamine challenge by bromocriptine for testing personality

Träber, F.

Brain plasticity, cognitive functioning and the relationship to treatment outcome in patients with tobacco dependence

Treffurth, Y.

Interference of psychopharmacological agents with substance P-induced gene expression and expression of the receptor for substance P

Treiber, K.

Hyperforin activates nonselective cation channels – A new mechanism of antidepressant activity

Tremblay, P.

Serotonin transporter gene polymorphism and response to lithium augmentation in patients with treatment-refractory depression

Trenkwalder, C.

Restaurative therapy for Parkinson’s disease
Evidence for genetic heterogeneity in Restless Legs Syndrome

Tsolakidou, A.

Antidepressants differentially influence the transcriptional activity of the glucocorticoid receptor in vitro

Tucha, O.

The impact of tricyclic antidepressants and selective serotonin re-uptake inhibitors on handwriting movements of patients with depression

Turck, C. W.

Validation of a genetic mouse model for anxiety and comorbid depression
Analysis of cerebrospinal fluid of depressed patients